Related Experiment Video
Updated: Apr 28, 2026

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
New sensitive one-step real-time duplex PCR method for group A and B HIV-2 RNA load
Véronique Avettand-Fenoel1, Florence Damond2, Marie Gueudin3
1Laboratoire de Virologie, AP-HP, Hôpital Necker Enfants Malades, Paris, France EA7327, Université Paris-Descartes, Sorbonne Paris Cité, Faculté de Médecine, Paris, France.
A new, highly sensitive HIV-2 RNA quantification assay was developed using TaqMan qRT-PCR. This method improves detection of low viral loads in HIV-2 patients, aiding in disease monitoring.
Area of Science:
- Virology
- Molecular Biology
- Clinical Diagnostics
Background:
- The Agence Nationale de Recherche sur le Sida et les hépatites virales (ANRS) previously established a standard HIV-1 RNA quantification method.
- Accurate quantification of Human Immunodeficiency Virus type 2 (HIV-2) RNA is crucial for patient management.
Purpose of the Study:
- To develop and validate a novel, sensitive, and specific assay for quantifying HIV-2 RNA.
- To adapt an existing HIV-1 RNA quantification protocol for HIV-2 detection.
Main Methods:
- Development of a TaqMan one-step reverse transcription-quantitative PCR (qRT-PCR) assay targeting conserved HIV-2 LTR and gag regions.
- Analytical performance assessment across three laboratories.
- Clinical performance evaluation using 100 plasma samples from HIV-2 infected patients (groups A, B, and H).
Main Results:
- The new assay demonstrated 100% specificity with a sensitivity of 50 copies/ml, optimized to 10 copies/ml.
- Within-run and between-run coefficients of variation were low, indicating good reproducibility.
- The assay improved detection or quantification of low viral loads in 17 out of 39 samples compared to the current assay, particularly for group B samples.
Conclusions:
- The developed HIV-2 RNA quantification assay is highly sensitive and accurate for prevalent HIV-2 groups.
- This new test offers significant advantages for monitoring low viral loads in HIV-2-infected individuals.
- The assay provides a valuable tool for clinical management and research in HIV-2 cohorts.
More Related Videos
08:37Development of a Quantitative Recombinase Polymerase Amplification Assay with an Internal Positive Control
Published on: March 30, 2015
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019